Astrana Health (NASDAQ:ASTH) Price Target Cut to $35.00 by Analysts at TD Cowen

Astrana Health (NASDAQ:ASTH) had its price objective reduced by investment analysts at TD Cowen from $40.00 to $35.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. TD Cowen’s price objective suggests a potential upside of 51.19% from the stock’s previous close.

ASTH has been the topic of several other research reports. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Astrana Health in a report on Wednesday, October 8th. Zacks Research raised Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. Finally, BTIG Research dropped their price target on Astrana Health from $50.00 to $45.00 and set a “buy” rating for the company in a research note on Friday. Six research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $45.29.

Astrana Health Price Performance

Shares of Astrana Health stock traded down $2.38 on Monday, reaching $23.15. The stock had a trading volume of 371,632 shares, compared to its average volume of 347,440. The business’s 50 day moving average is $30.44 and its two-hundred day moving average is $27.89. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.52. Astrana Health has a 1 year low of $21.20 and a 1 year high of $48.63. The company has a market cap of $1.30 billion, a P/E ratio of 45.58, a price-to-earnings-growth ratio of 0.90 and a beta of 0.80.

Astrana Health (NASDAQ:ASTH) last posted its earnings results on Wednesday, January 10th. The company reported $0.50 earnings per share for the quarter. Astrana Health had a net margin of 1.04% and a return on equity of 3.43%. The business had revenue of $317.00 million for the quarter. As a group, research analysts anticipate that Astrana Health will post 1.15 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of ASTH. Principal Financial Group Inc. raised its position in Astrana Health by 2.3% during the 1st quarter. Principal Financial Group Inc. now owns 221,896 shares of the company’s stock valued at $6,881,000 after purchasing an additional 4,963 shares during the last quarter. Hussman Strategic Advisors Inc. grew its position in shares of Astrana Health by 33.3% in the 1st quarter. Hussman Strategic Advisors Inc. now owns 84,000 shares of the company’s stock worth $2,605,000 after buying an additional 21,000 shares during the last quarter. Allianz Asset Management GmbH increased its stake in shares of Astrana Health by 32.5% during the first quarter. Allianz Asset Management GmbH now owns 32,600 shares of the company’s stock valued at $1,011,000 after buying an additional 8,000 shares during the period. Diamond Hill Capital Management Inc. raised its holdings in shares of Astrana Health by 32.6% during the first quarter. Diamond Hill Capital Management Inc. now owns 211,038 shares of the company’s stock valued at $6,544,000 after acquiring an additional 51,827 shares in the last quarter. Finally, Royce & Associates LP lifted its stake in Astrana Health by 13.8% in the first quarter. Royce & Associates LP now owns 290,707 shares of the company’s stock worth $9,015,000 after acquiring an additional 35,155 shares during the period. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.